References: Alzahrani, H, Mutwakil, M, Sabir, J, Saini, K, Alarif, W, Rizgallah, MR. Anticancer and antibacterial activity of Calotropis procera leaf extract. J Basic Appl Sci Res 2017;7:18–25.
Begum, N, Sharma, B, Pandey, R. Evaluation of insecticidal efficacy of Calotropis procera and Annona squamosa ethanol extracts against Musca domestica. J Biofertil Biopestic 2010;1:101.
Mijatovic, T, Van Quaquebeke, E, Delest, B, Debeir, O, Darro, F, Kiss, R. Cardiotonic steroids on the road to anti-cancer therapy. Biochim Biophys Acta 2007;1776:32–57. https://doi.org/10.1016/j.bbcan.2007.06.002.
Mijatovic, T, Op De Beeck, A, Van Quaquebeke, E, Dewelle, J, Darro, F, de Launoit, Y, et al.. The cardenolide UNBS1450 is able to deactivate nuclear factor kappaB-mediated cytoprotective effects in human non-small cell lung cancer cells. Mol Canc Ther 2006;5:391–9. https://doi.org/10.1158/1535-7163.mct-05-0367.
Hosseini, SH, Masullo, M, Cerulli, A, Martucciello, S, Ayyari, M, Pizza, C, et al.. Antiproliferative Cardenolides from the aerial parts of Pergularia tomentosa. J Nat Prod 2019;82:74–9. https://doi.org/10.1021/acs.jnatprod.8b00630.
Van Quaquebeke, E, Simon, G, André, A, Dewelle, J, El Yazidi, M, Bruyneel, F, et al.. Identification of a novel cardenolide (2’’-oxovoruscharin) from Calotropis procera and the hemisynthesis of novel derivatives displaying potent in vitro antitumor activities and high in vivo tolerance: structure-activity relationship analyses. J Med Chem 2005;48:849–56. https://doi.org/10.1021/jm049405a.
Piacente, S, Masullo, M, De Nève, N, Dewelle, J, Hamed, A, Kiss, R, et al.. Cardenolides from Pergularia tomentosa display Cytotoxic activity resulting from their Potent inhibition of Na+/K+-ATPase. J Nat Prod 2009;72:1087–91. https://doi.org/10.1021/np800810f.
Al-Eisawi, DM. Field guide to wild flowers of Jordan and neighbouring countries. Amman: Jordan Press Foundation “Al Rai”; 1998.
Sweidan, NI, Abu Zarga, MH. Two novel cardenolides from Calotropis procera. J Asian Nat Prod Res 2015;17:900–7. https://doi.org/10.1080/10286020.2015.1040772.
Hanahan, D, Weinberg, RA. Hallmarks of cancer: the next generation. Cell 2011;144:646–74. https://doi.org/10.1016/j.cell.2011.02.013.
Sarfati, D, Gurney, J, Stanley, J, Salmond, C, Crampton, P, Dennett, E, et al.. Cancer-specific administrative data–based comorbidity indices provided valid alternative to Charlson and National Cancer Institute Indices. J Clin Epidemiol 2014;67:586–95. https://doi.org/10.1016/j.jclinepi.2013.11.012.
Cheung, HTA, Chiu, FCK, Watson, TR, Wells, RJ. Cardenolide glycosides of the asclepiadaceae. New glycosides from Asclepias fruticosa and the stereochemistry of uscharin, voruscharin and calotoxin. J Chem Soc Perkin Trans 1983;1:2827–35. https://doi.org/10.1039/p19830002827.
Tian, L, Xie, XH, Zhu, ZH. Calotropin regulates the apoptosis of non-small cell cancer by regulating the cytotoxic T-lymphocyte associated antigen 4-mediated TGF-β/ERK signaling pathway. Mol Med Rep 2018;17:7683–91. https://doi.org/10.3892/mmr.2018.8853.
Choedon, T, Mathan, G, Arya, S, Kumar, VL, Kumar, V. Anticancer and cytotoxic properties of the latex of Calotropis procera in a transgenic mouse model of hepatocellular carcinoma. World J Gastroenterol 2006;12:2517–22. https://doi.org/10.3748/wjg.v12.i16.2517.
Bhagat, M, Arora, JS, Saxena, AK. In vitro cytotoxicity of extracts and fractions of Calotropis procera (Ait.) roots against human cancer cell lines. Int J Green Pharm 2010;4:36–40.
Van Quaquebeke, E, Simon, G, André, A, Dewelle, J, Yazidi, ME, Bruyneel, F, et al.. Identification of a novel Cardenolide (2’’-oxovoruscharin) from Calotropis procera and the hemisynthesis of novel derivatives displaying Potent in vitro antitumor activities and high in vivo tolerance: structure−activity relationship analyses. J Med Chem 2005;48:849–56. https://doi.org/10.1021/jm049405a.
Joshi, AL, Roham, PH, Mhaske, R, Jadhav, M, Krishnadas, K, Kharat, A, et al.. Calotropis procera extract induces apoptosis and cell cycle arrest at G2/M phase in human skin melanoma (SK-MEL-2) cells. Nat Prod Res 2015;29:2261–4. https://doi.org/10.1080/14786419.2014.1001386.
English, DP, Roque, DM, Santin, AD. HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies. Mol Diagn Ther 2013;17:85–99. https://doi.org/10.1007/s40291-013-0024-9.
Sriwiriyajan, S, Ninpesh, T, Sukpondma, Y, Nasomyon, T, Graidist, P. Cytotoxicity screening of plants of genus Piper in breast cancer cell lines. Trop J Pharm Res 2014;13:921–8.
Barta, JA, Powell, CA, Wisnivesky, JPJ. Global epidemiology of lung cancer. Ann Glob Health 2019;85:1–16. https://doi.org/10.5334/aogh.2419.
No Comments.